<htmlform formUuid="3af3f492-21e5-4a4a-87c9-0f2dae364ec2" formName="DR-TB In-Patient Discharge Form" formEncounterType="be400d24-f75f-453a-baf2-c5c3e555ec0f" formVersion="1.0">
    <!-- Autogenerated example form  (template from 01-Nov-2010 -->
    <macros>
        paperFormId = (Fill this in)
        headerColor =#009d8e
        fontOnHeaderColor = white
    </macros>

    <style>
        .section {
            border: 1px solid $headerColor;
            padding: 2px;
            text-align: left;
            margin-bottom: 1em;
        }
        .sectionHeader {
            background-color: #2f1c55;
            color: white;
            /* display: block; */
            padding: 2px;
            font-weight: bold;
        }
        table tr:nth-child(even) {
            background: #ffffff;
        }
        .alnright{
            text-align: right;
            color:#000000;
            width: 25%;
        }
        .alnright_s{
            text-align: right;
            color:#000000;
            width: 13%;
        }
        .alnleft_s{
            text-align: left;
            color:#000000;
            width: 13%;
        }
        .alnleft_f{
            text-align: left;
            color:#000000;
            width: 20%;
        }
        .alnleft_f1{
            text-align: left;
            color:#000000;
            width: 20%;
        }
        .alnleft_ns{
            text-align: left;
            color:#000000;
            width: 13%;
        }
        .alnleft{
            text-align: left;
            color:#000000;
            width: 25%;
        }
        .error{
            color:red;
        }
        td {
            border: none;
        }
        table th, table td {
            padding: 5px 10px;
            border: None;
        }
        .legend_style {
            max-width: 35%;
            background: #FAFAFA;
            /*   padding: 5px; */
            margin: 20px left;
            box-shadow: 1px 1px 25px rgba(0,0,0,0.10);
            border-radius: 2px;
            border: 1px solid #305a72;
            border-bottom-left-radius: 2px;
            margin-bottom: 20px;
            text-transform:initial;
        }
        form fieldset, .form fieldset {
            min-width: 98%;
            border: none;
            border-top: 1px solid #305a72;
            margin-bottom: 20px;


        }
        table th, table td {
            padding: 5px 10px;
            /* border: 1px solid #DDD; */
        }
        table tr {
            border: None;
        }
        ul.select, .form input, .form select, .form textarea, .form ul.select {
            padding: 2px 10px;
        }
        form input, form select, form textarea, form ul.select, .form input, .form select, .form textarea, .form ul.select {
            padding: 2px 10px;
        }
        form select, .form select {
            max-width: 200px;
            min-width: 150px;
        }
        .standard {
            max-width: 200px;
            min-width: 150px;
        }
        body {
            font-family: "OpenSans", Arial, sans-serif;
            color: #363463;
            font-size: 14px;
        }
        /* table.baseline-aligned td {
            vertical-align: baseline;
            } */
    </style>

    <script type="text/javascript">
        var $ = jQuery;
        $(document).ready(function() {
            $('.hasDatepicker').attr('readonly', true)
        });
    </script>

    <table style="margin-bottom: 30px;">
        <thead>
        <tr><th  style="text-align: center"><em>DR-TB In-Patient Discharge Form</em></th></tr>
        </thead>
    </table>


    <fieldset>
        <legend class="legend_style">DR-TB Admission Details</legend>
        <table border="0" width="100%" height="50">
            <tr>

                <td width="60%" height="50%"> DR-TB Treatment Centre<br/>
                    <obs conceptId="166818"  />
                </td>
                <td width="40%" height="50%"> DR-TB State<br/>
                    <obs conceptId="166819"  />
                </td>
            </tr>
        </table>

        <table border="0" width="100%" height="50">
            <tr>
                <td width="60%" height="50%">Date of DR-TB Admission<br/>
                    <obs conceptId="166820"  allowTime="false"/>
                </td>
                <td width="40%" height="50%"> Date of DR-TB Discharge<br/>
                    <obs conceptId="166821"  />
                </td>
            </tr>
        </table>
        <table border="0" width="100%" height="50">
            <tr>
                <td width="60%" height="50%"> DR-TB Registration No:<br/>
                    <obs conceptId="166822"  />
                </td>
                <td width="40%" height="50%"> Date of DR-TB Registration<br/>
                    <obs conceptId="166823"  />
                </td>
            </tr>

        </table>
        <table border="0" width="100%" height="50">
            <tr>
                <td width="60%" height="50%">Date of Treatment Initiation:<br/>
                    <obs conceptId="166824"  />
                </td>
                <!--  <td width="60%" height="50%"> Health Facility Number<br/>
                      <obs conceptId="166825"  />
                  </td> -->
            </tr>

        </table>

    </fieldset>

    <fieldset>
        <legend class="legend_style">DR-TB Discharge details</legend>
        <table>
            <tr>
                <td class="alnleft_f"> Facility Patient is Discharged to:<br/>
                    <obs conceptId="165508"  />
                </td>
                <td class="alnleft_s"> LGA of State<br/>
                    <obs conceptId="166015"  />
                </td>
            </tr>

        </table>

    </fieldset>


    <fieldset>
        <legend class="legend_style">DR-TB Treatment Regimen and Duration</legend>
        <table>
            <tr>
                <td width="13%">Any co-morbidity?</td>
                <td width="13%">
                    <obs id="tb_morbidity" conceptId="166662" answerConceptIds="1065,1066" answerLabels="Yes,No" >
                        <controls>
                            <when value="1065" thenDisplay="#Specify_Details"/>
                        </controls>
                    </obs>
                </td>

            </tr>
            <tr id="Specify_Details" >
                <td> Specify Co-morbidities: </td>
                <td  style="width: auto;">
                    <obs conceptId="166663"/>
                </td>
                <td> Specify Drug used: </td>
                <td  colspan="4" style="width: auto;">
                    <obs conceptId="166663"/>
                </td>
            </tr>
        </table>
    </fieldset>

    <fieldset>
        <legend class="legend_style">Intensive Phase</legend>
        <table class="baseline-aligned">
            <tr>
                <td> Short Regimen </td>
                <td> Composition</td>
            </tr>
            <tr>
                <td>
                    <obs conceptId="166979" answerConceptIds="166976,166973,166967,166969,166972,166961,166964" answerLabels="WHO Short Oral MDR-TB,Short Oral MDR-TB,Short Oral PreXDR-TB (FQ resistant BPaL),Long oral MDR/RR-TB,PreXDR-TB (resistant to FQ),Fluoroquinolone susceptible,Fluoroquinolone resistant"/>
                </td>
                <td>
                    <obs conceptId="166980" answerConceptIds="166977,166974,166968,166970,166962,166965" answerLabels="4-6 Bdq -Mfx- Cfz-Hh-Pto-E-Z,4-6 Bdq (4)-hLfx-Lzd-Cfz,6 Bdq-Pmn-Lzd,6Bdq-Mfx*-Cfz-Lzd, 6 Mfx-Lzd-Cfz-Dlm,6 Lzd-Cfz-Dlm*-Cs"/>
                </td>
            </tr>

            <tr>
                <td> Drugs</td>
                <td> Duration </td>
            </tr>
            <tr>
                <obsGroup groupingConceptId="166983">
                    <td>
                        <obs conceptId="166981" answerConceptIds="166976,166973,166967,166969,166972,166961,166964,166843,767,75948,82900,84360,72794,78385,71060,73449,81022,78788,80133,75976,74123,81457,82772,160019,450,73498,83352,73581,84836,160020,82912,76835" answerLabels="WHO Short Oral MDR-TB,Short Oral MDR-TB,Short Oral PreXDR-TB (FQ resistant BPaL),Long oral MDR/RR-TB,PreXDR-TB (resistant to FQ),Fluoroquinolone susceptible,Fluoroquinolone resistant,HIGH DOSE ISONIAZID,RIFAMPICIN,ETHAMBUTOL,PYRAZINAMIDE,STREPTOMYCIN,CAPREOMYCIN,KANAMYCIN,AMIKACIN,CIPROFLOXACIN,OFLOXACIN,LEVOFLOXACIN,MOXIFLOXACIN,ETHIONAMIDE,CYCLOSERINE,P-AMINOSALICYLIC ACID,PROTHIONAMIDE,THIOACETAZONE,AMOXICILLIN AND CLAVULANIC ACID,CLARITHROMYCIN,RIFABUTIN,CLOFAZIMINE,TERIZIDONE,Viomycin,PYRIDOXINE,GATIFLOXACIN"/>
                    </td>
                    <td>
                        <obs conceptId="166982" answerConceptIds="166667,166668,166670" answerLabels="4 months,5 months,6 months" />
                    </td>
                </obsGroup>
            </tr>
            <tr>
                <obsGroup groupingConceptId="166983">
                    <td>
                        <obs conceptId="166981" answerConceptIds="166976,166973,166967,166969,166972,166961,166964,166843,767,75948,82900,84360,72794,78385,71060,73449,81022,78788,80133,75976,74123,81457,82772,160019,450,73498,83352,73581,84836,160020,82912,76835" answerLabels="WHO Short Oral MDR-TB,Short Oral MDR-TB,Short Oral PreXDR-TB (FQ resistant BPaL),Long oral MDR/RR-TB,PreXDR-TB (resistant to FQ),Fluoroquinolone susceptible,Fluoroquinolone resistant,HIGH DOSE ISONIAZID,RIFAMPICIN,ETHAMBUTOL,PYRAZINAMIDE,STREPTOMYCIN,CAPREOMYCIN,KANAMYCIN,AMIKACIN,CIPROFLOXACIN,OFLOXACIN,LEVOFLOXACIN,MOXIFLOXACIN,ETHIONAMIDE,CYCLOSERINE,P-AMINOSALICYLIC ACID,PROTHIONAMIDE,THIOACETAZONE,AMOXICILLIN AND CLAVULANIC ACID,CLARITHROMYCIN,RIFABUTIN,CLOFAZIMINE,TERIZIDONE,Viomycin,PYRIDOXINE,GATIFLOXACIN"/>
                    </td>
                    <td>
                        <obs conceptId="166982" answerConceptIds="166667,166668,166670" answerLabels="4 months,5 months,6 months" />
                    </td>
                </obsGroup>
            </tr>
            <tr>
                <obsGroup groupingConceptId="166983">
                    <td>
                        <obs conceptId="166981" answerConceptIds="166976,166973,166967,166969,166972,166961,166964,166843,767,75948,82900,84360,72794,78385,71060,73449,81022,78788,80133,75976,74123,81457,82772,160019,450,73498,83352,73581,84836,160020,82912,76835" answerLabels="WHO Short Oral MDR-TB,Short Oral MDR-TB,Short Oral PreXDR-TB (FQ resistant BPaL),Long oral MDR/RR-TB,PreXDR-TB (resistant to FQ),Fluoroquinolone susceptible,Fluoroquinolone resistant,HIGH DOSE ISONIAZID,RIFAMPICIN,ETHAMBUTOL,PYRAZINAMIDE,STREPTOMYCIN,CAPREOMYCIN,KANAMYCIN,AMIKACIN,CIPROFLOXACIN,OFLOXACIN,LEVOFLOXACIN,MOXIFLOXACIN,ETHIONAMIDE,CYCLOSERINE,P-AMINOSALICYLIC ACID,PROTHIONAMIDE,THIOACETAZONE,AMOXICILLIN AND CLAVULANIC ACID,CLARITHROMYCIN,RIFABUTIN,CLOFAZIMINE,TERIZIDONE,Viomycin,PYRIDOXINE,GATIFLOXACIN"/>
                    </td>
                    <td>
                        <obs conceptId="166982" answerConceptIds="166667,166668,166670" answerLabels="4 months,5 months,6 months" />
                    </td>
                </obsGroup>
            </tr>
            <tr>
                <obsGroup groupingConceptId="166983">
                    <td>
                        <obs conceptId="166981" answerConceptIds="166976,166973,166967,166969,166972,166961,166964,166843,767,75948,82900,84360,72794,78385,71060,73449,81022,78788,80133,75976,74123,81457,82772,160019,450,73498,83352,73581,84836,160020,82912,76835" answerLabels="WHO Short Oral MDR-TB,Short Oral MDR-TB,Short Oral PreXDR-TB (FQ resistant BPaL),Long oral MDR/RR-TB,PreXDR-TB (resistant to FQ),Fluoroquinolone susceptible,Fluoroquinolone resistant,HIGH DOSE ISONIAZID,RIFAMPICIN,ETHAMBUTOL,PYRAZINAMIDE,STREPTOMYCIN,CAPREOMYCIN,KANAMYCIN,AMIKACIN,CIPROFLOXACIN,OFLOXACIN,LEVOFLOXACIN,MOXIFLOXACIN,ETHIONAMIDE,CYCLOSERINE,P-AMINOSALICYLIC ACID,PROTHIONAMIDE,THIOACETAZONE,AMOXICILLIN AND CLAVULANIC ACID,CLARITHROMYCIN,RIFABUTIN,CLOFAZIMINE,TERIZIDONE,Viomycin,PYRIDOXINE,GATIFLOXACIN"/>
                    </td>
                    <td>
                        <obs conceptId="166982" answerConceptIds="166667,166668,166670" answerLabels="4 months,5 months,6 months" />
                    </td>
                </obsGroup>
            </tr>
            <tr>
                <obsGroup groupingConceptId="166983">
                    <td>
                        <obs conceptId="166981" answerConceptIds="166976,166973,166967,166969,166972,166961,166964,166843,767,75948,82900,84360,72794,78385,71060,73449,81022,78788,80133,75976,74123,81457,82772,160019,450,73498,83352,73581,84836,160020,82912,76835" answerLabels="WHO Short Oral MDR-TB,Short Oral MDR-TB,Short Oral PreXDR-TB (FQ resistant BPaL),Long oral MDR/RR-TB,PreXDR-TB (resistant to FQ),Fluoroquinolone susceptible,Fluoroquinolone resistant,HIGH DOSE ISONIAZID,RIFAMPICIN,ETHAMBUTOL,PYRAZINAMIDE,STREPTOMYCIN,CAPREOMYCIN,KANAMYCIN,AMIKACIN,CIPROFLOXACIN,OFLOXACIN,LEVOFLOXACIN,MOXIFLOXACIN,ETHIONAMIDE,CYCLOSERINE,P-AMINOSALICYLIC ACID,PROTHIONAMIDE,THIOACETAZONE,AMOXICILLIN AND CLAVULANIC ACID,CLARITHROMYCIN,RIFABUTIN,CLOFAZIMINE,TERIZIDONE,Viomycin,PYRIDOXINE,GATIFLOXACIN"/>
                    </td>
                    <td>
                        <obs conceptId="166982" answerConceptIds="166667,166668,166670" answerLabels="4 months,5 months,6 months" />
                    </td>
                </obsGroup>
            </tr>
        </table>
    </fieldset>
    <fieldset>
        <legend class="legend_style">Continuity Phase</legend>
        <table>
            <tr>
                <td> Short Regimen </td>
                <td> Composition</td>
            </tr>
            <tr>
                <td>
                    <obs conceptId="166979" answerConceptIds="166976,166973,166967,166969,166972,166961,166964" answerLabels="WHO Short Oral MDR-TB,Short Oral MDR-TB,Short Oral PreXDR-TB (FQ resistant BPaL),Long oral MDR/RR-TB,PreXDR-TB (resistant to FQ),Fluoroquinolone susceptible,Fluoroquinolone resistant"/>
                </td>
                <td>
                    <obs conceptId="166980" answerConceptIds="166978,166975,166968,166971,166963,166966" answerLabels="5Mfx-Cfz-E-Z,5Bdq (2)â€“hLfx-Lzd-Cfz,6 Bdq-Pmn-Lzd,12Mfx-Cfz-Lzd,12Cfz-Lzd-Cs,6 Mfx-Lzd-Cfz,6 Lzd-Cfz-Cs"/>
                </td>
            </tr>


            <tr>
                <td> Drugs</td>
                <td> Duration </td>
            </tr>
            <tr>
                <obsGroup groupingConceptId="166984">
                    <td>
                        <obs conceptId="166981" answerConceptIds="166976,166973,166967,166969,166972,166961,166964,166843,767,75948,82900,84360,72794,78385,71060,73449,81022,78788,80133,75976,74123,81457,82772,160019,450,73498,83352,73581,84836,160020,82912,76835" answerLabels="WHO Short Oral MDR-TB,Short Oral MDR-TB,Short Oral PreXDR-TB (FQ resistant BPaL),Long oral MDR/RR-TB,PreXDR-TB (resistant to FQ),Fluoroquinolone susceptible,Fluoroquinolone resistant,HIGH DOSE ISONIAZID,RIFAMPICIN,ETHAMBUTOL,PYRAZINAMIDE,STREPTOMYCIN,CAPREOMYCIN,KANAMYCIN,AMIKACIN,CIPROFLOXACIN,OFLOXACIN,LEVOFLOXACIN,MOXIFLOXACIN,ETHIONAMIDE,CYCLOSERINE,P-AMINOSALICYLIC ACID,PROTHIONAMIDE,THIOACETAZONE,AMOXICILLIN AND CLAVULANIC ACID,CLARITHROMYCIN,RIFABUTIN,CLOFAZIMINE,TERIZIDONE,Viomycin,PYRIDOXINE,GATIFLOXACIN"/>
                    </td>
                    <td>
                        <obs conceptId="166982" answerConceptIds="166985,166668,166670" answerLabels="5 months,6 months,12 months" />
                    </td>
                </obsGroup>
            </tr>
            <tr>
                <obsGroup groupingConceptId="166984">
                    <td>
                        <obs conceptId="166981" answerConceptIds="166976,166973,166967,166969,166972,166961,166964,166843,767,75948,82900,84360,72794,78385,71060,73449,81022,78788,80133,75976,74123,81457,82772,160019,450,73498,83352,73581,84836,160020,82912,76835" answerLabels="WHO Short Oral MDR-TB,Short Oral MDR-TB,Short Oral PreXDR-TB (FQ resistant BPaL),Long oral MDR/RR-TB,PreXDR-TB (resistant to FQ),Fluoroquinolone susceptible,Fluoroquinolone resistant,HIGH DOSE ISONIAZID,RIFAMPICIN,ETHAMBUTOL,PYRAZINAMIDE,STREPTOMYCIN,CAPREOMYCIN,KANAMYCIN,AMIKACIN,CIPROFLOXACIN,OFLOXACIN,LEVOFLOXACIN,MOXIFLOXACIN,ETHIONAMIDE,CYCLOSERINE,P-AMINOSALICYLIC ACID,PROTHIONAMIDE,THIOACETAZONE,AMOXICILLIN AND CLAVULANIC ACID,CLARITHROMYCIN,RIFABUTIN,CLOFAZIMINE,TERIZIDONE,Viomycin,PYRIDOXINE,GATIFLOXACIN"/>
                    </td>
                    <td>
                        <obs conceptId="166982" answerConceptIds="166985,166668,166670" answerLabels="5 months,6 months,12 months" />
                    </td>
                </obsGroup>
            </tr>
            <tr>
                <obsGroup groupingConceptId="166984">
                    <td>
                        <obs conceptId="166981" answerConceptIds="166976,166973,166967,166969,166972,166961,166964,166843,767,75948,82900,84360,72794,78385,71060,73449,81022,78788,80133,75976,74123,81457,82772,160019,450,73498,83352,73581,84836,160020,82912,76835" answerLabels="WHO Short Oral MDR-TB,Short Oral MDR-TB,Short Oral PreXDR-TB (FQ resistant BPaL),Long oral MDR/RR-TB,PreXDR-TB (resistant to FQ),Fluoroquinolone susceptible,Fluoroquinolone resistant,HIGH DOSE ISONIAZID,RIFAMPICIN,ETHAMBUTOL,PYRAZINAMIDE,STREPTOMYCIN,CAPREOMYCIN,KANAMYCIN,AMIKACIN,CIPROFLOXACIN,OFLOXACIN,LEVOFLOXACIN,MOXIFLOXACIN,ETHIONAMIDE,CYCLOSERINE,P-AMINOSALICYLIC ACID,PROTHIONAMIDE,THIOACETAZONE,AMOXICILLIN AND CLAVULANIC ACID,CLARITHROMYCIN,RIFABUTIN,CLOFAZIMINE,TERIZIDONE,Viomycin,PYRIDOXINE,GATIFLOXACIN"/>
                    </td>
                    <td>
                        <obs conceptId="166982" answerConceptIds="166985,166668,166670" answerLabels="5 months,6 months,12 months" />
                    </td>
                </obsGroup>
            </tr>
            <tr>
                <obsGroup groupingConceptId="166984">
                    <td>
                        <obs conceptId="166981" answerConceptIds="166976,166973,166967,166969,166972,166961,166964,166843,767,75948,82900,84360,72794,78385,71060,73449,81022,78788,80133,75976,74123,81457,82772,160019,450,73498,83352,73581,84836,160020,82912,76835" answerLabels="WHO Short Oral MDR-TB,Short Oral MDR-TB,Short Oral PreXDR-TB (FQ resistant BPaL),Long oral MDR/RR-TB,PreXDR-TB (resistant to FQ),Fluoroquinolone susceptible,Fluoroquinolone resistant,HIGH DOSE ISONIAZID,RIFAMPICIN,ETHAMBUTOL,PYRAZINAMIDE,STREPTOMYCIN,CAPREOMYCIN,KANAMYCIN,AMIKACIN,CIPROFLOXACIN,OFLOXACIN,LEVOFLOXACIN,MOXIFLOXACIN,ETHIONAMIDE,CYCLOSERINE,P-AMINOSALICYLIC ACID,PROTHIONAMIDE,THIOACETAZONE,AMOXICILLIN AND CLAVULANIC ACID,CLARITHROMYCIN,RIFABUTIN,CLOFAZIMINE,TERIZIDONE,Viomycin,PYRIDOXINE,GATIFLOXACIN"/>
                    </td>
                    <td>
                        <obs conceptId="166982" answerConceptIds="166985,166668,166670" answerLabels="5 months,6 months,12 months" />
                    </td>
                </obsGroup>
            </tr>
            <tr>
                <obsGroup groupingConceptId="166984">
                    <td>
                        <obs conceptId="166981" answerConceptIds="166976,166973,166967,166969,166972,166961,166964,166843,767,75948,82900,84360,72794,78385,71060,73449,81022,78788,80133,75976,74123,81457,82772,160019,450,73498,83352,73581,84836,160020,82912,76835" answerLabels="WHO Short Oral MDR-TB,Short Oral MDR-TB,Short Oral PreXDR-TB (FQ resistant BPaL),Long oral MDR/RR-TB,PreXDR-TB (resistant to FQ),Fluoroquinolone susceptible,Fluoroquinolone resistant,HIGH DOSE ISONIAZID,RIFAMPICIN,ETHAMBUTOL,PYRAZINAMIDE,STREPTOMYCIN,CAPREOMYCIN,KANAMYCIN,AMIKACIN,CIPROFLOXACIN,OFLOXACIN,LEVOFLOXACIN,MOXIFLOXACIN,ETHIONAMIDE,CYCLOSERINE,P-AMINOSALICYLIC ACID,PROTHIONAMIDE,THIOACETAZONE,AMOXICILLIN AND CLAVULANIC ACID,CLARITHROMYCIN,RIFABUTIN,CLOFAZIMINE,TERIZIDONE,Viomycin,PYRIDOXINE,GATIFLOXACIN"/>
                    </td>
                    <td>
                        <obs conceptId="166982" answerConceptIds="166985,166668,166670" answerLabels="5 months,6 months,12 months" />
                    </td>
                </obsGroup>
            </tr>

        </table>

    </fieldset>

    <fieldset >

        <table style="margin-top: 20px;">

            <tr>

                <td width="13%">Any Adverse reaction while patients was on Treatment:</td>
                <td width="13%">
                    <obs id="tb_Reaction" style="yes_no_dropdown" conceptId="166673" answerConceptIds="1065,1066">
                        <controls>
                            <when value="1065" thenDisplay="#Specify_typeOfAdverse"/>
                        </controls>
                    </obs>
                </td>

            </tr>

        </table>
    </fieldset>
    <!-- Adverse Drugs Update session -->

    <fieldset id="Specify_typeOfAdverse">
        <legend>Adverse reaction</legend>
        <table>
            <tr><td>Type</td>  <td>Date</td><td>Management</td><td>Other Comments</td></tr>
            <tr>
                <obsGroup groupingConceptId="166676">
                    <td class="alnleft_s"><obs conceptId="166674" answerConceptIds="166839,215,29,159298,112989,113478,121849,868,5978,151,80,75948,166840" answerLabels="Skin rash with or without Itching,Jaundice,hepatitis,Visual Impairment,shock,Purpura,acute renal failure,Anorexia,Nausea,Abdominal pain,Joint pains,Burning/numbness in the hands/ feet,Orange/red urine"/></td>
                    <td class="alnleft_s"><obs conceptId="166664"/></td>
                    <td class="alnleft_s"><obs conceptId="166677" answerConceptIds="166986,166987,166988,166989,166990,166991,166992,166993,166994,166995,166996,166997,166998,166999,167000,167001" answerLabels="Stop anti-TB drugs,Stop anti-TB drugs and refer to the Medical Officer,Stop ethambutol,Stop ethambutol and refer to the Medical Officer,Stop rifampicin,Stop rifampicin and refer to the Medical Officer,Give drugs with small meals or just before bedtime,Advise patient to swallow pills slowly with small sips of water,Advise patient to swallow pills slowly with small sips of water ; If symptoms persist or worsen refer to hospital,Pyridoxine 50 -100mg daily,Reassurance, Counsel patients before starting treatment,encourage increase fluid intake,Reassure and counsel patients before starting treatment and encourage increase fluid intake,Give drugs before bedtime,Change intermittent to daily rifampicin administration"/></td>
                    <td><obs conceptId="167002"/></td>
                </obsGroup>
            </tr>
            <tr>
                <obsGroup groupingConceptId="166676">
                    <td class="alnleft_s"><obs conceptId="166674" answerConceptIds="166839,215,29,159298,112989,113478,121849,868,5978,151,80,75948,166840" answerLabels="Skin rash with or without Itching,Jaundice,hepatitis,Visual Impairment,shock,Purpura,acute renal failure,Anorexia,Nausea,Abdominal pain,Joint pains,Burning/numbness in the hands/ feet,Orange/red urine"/></td>
                    <td class="alnleft_s"><obs conceptId="166664"/></td>
                    <td class="alnleft_s"><obs conceptId="166677" answerConceptIds="166986,166987,166988,166989,166990,166991,166992,166993,166994,166995,166996,166997,166998,166999,167000,167001" answerLabels="Stop anti-TB drugs,Stop anti-TB drugs and refer to the Medical Officer,Stop ethambutol,Stop ethambutol and refer to the Medical Officer,Stop rifampicin,Stop rifampicin and refer to the Medical Officer,Give drugs with small meals or just before bedtime,Advise patient to swallow pills slowly with small sips of water,Advise patient to swallow pills slowly with small sips of water ; If symptoms persist or worsen refer to hospital,Pyridoxine 50 -100mg daily,Reassurance, Counsel patients before starting treatment,encourage increase fluid intake,Reassure and counsel patients before starting treatment and encourage increase fluid intake,Give drugs before bedtime,Change intermittent to daily rifampicin administration"/></td>
                    <td><obs conceptId="167002"/></td>
                </obsGroup>
            </tr>
            <tr>
                <obsGroup groupingConceptId="166676">
                    <td class="alnleft_s"><obs conceptId="166674" answerConceptIds="166839,215,29,159298,112989,113478,121849,868,5978,151,80,75948,166840" answerLabels="Skin rash with or without Itching,Jaundice,hepatitis,Visual Impairment,shock,Purpura,acute renal failure,Anorexia,Nausea,Abdominal pain,Joint pains,Burning/numbness in the hands/ feet,Orange/red urine"/></td>
                    <td class="alnleft_s"><obs conceptId="166664"/></td>
                    <td class="alnleft_s"><obs conceptId="166677" answerConceptIds="166986,166987,166988,166989,166990,166991,166992,166993,166994,166995,166996,166997,166998,166999,167000,167001" answerLabels="Stop anti-TB drugs,Stop anti-TB drugs and refer to the Medical Officer,Stop ethambutol,Stop ethambutol and refer to the Medical Officer,Stop rifampicin,Stop rifampicin and refer to the Medical Officer,Give drugs with small meals or just before bedtime,Advise patient to swallow pills slowly with small sips of water,Advise patient to swallow pills slowly with small sips of water ; If symptoms persist or worsen refer to hospital,Pyridoxine 50 -100mg daily,Reassurance, Counsel patients before starting treatment,encourage increase fluid intake,Reassure and counsel patients before starting treatment and encourage increase fluid intake,Give drugs before bedtime,Change intermittent to daily rifampicin administration"/></td>
                    <td><obs conceptId="167002"/></td>
                </obsGroup>
            </tr>
            <tr>
                <obsGroup groupingConceptId="166676">
                    <td class="alnleft_s"><obs conceptId="166674" answerConceptIds="166839,215,29,159298,112989,113478,121849,868,5978,151,80,75948,166840" answerLabels="Skin rash with or without Itching,Jaundice,hepatitis,Visual Impairment,shock,Purpura,acute renal failure,Anorexia,Nausea,Abdominal pain,Joint pains,Burning/numbness in the hands/ feet,Orange/red urine"/></td>
                    <td class="alnleft_s"><obs conceptId="166664"/></td>
                    <td class="alnleft_s"><obs conceptId="166677" answerConceptIds="166986,166987,166988,166989,166990,166991,166992,166993,166994,166995,166996,166997,166998,166999,167000,167001" answerLabels="Stop anti-TB drugs,Stop anti-TB drugs and refer to the Medical Officer,Stop ethambutol,Stop ethambutol and refer to the Medical Officer,Stop rifampicin,Stop rifampicin and refer to the Medical Officer,Give drugs with small meals or just before bedtime,Advise patient to swallow pills slowly with small sips of water,Advise patient to swallow pills slowly with small sips of water ; If symptoms persist or worsen refer to hospital,Pyridoxine 50 -100mg daily,Reassurance, Counsel patients before starting treatment,encourage increase fluid intake,Reassure and counsel patients before starting treatment and encourage increase fluid intake,Give drugs before bedtime,Change intermittent to daily rifampicin administration"/></td>
                    <td><obs conceptId="167002"/></td>
                </obsGroup>
            </tr>
            <tr>
                <obsGroup groupingConceptId="166676">
                    <td class="alnleft_s"><obs conceptId="166674" answerConceptIds="166839,215,29,159298,112989,113478,121849,868,5978,151,80,75948,166840" answerLabels="Skin rash with or without Itching,Jaundice,hepatitis,Visual Impairment,shock,Purpura,acute renal failure,Anorexia,Nausea,Abdominal pain,Joint pains,Burning/numbness in the hands/ feet,Orange/red urine"/></td>
                    <td class="alnleft_s"><obs conceptId="166664"/></td>
                    <td class="alnleft_s"><obs conceptId="166677" answerConceptIds="166986,166987,166988,166989,166990,166991,166992,166993,166994,166995,166996,166997,166998,166999,167000,167001" answerLabels="Stop anti-TB drugs,Stop anti-TB drugs and refer to the Medical Officer,Stop ethambutol,Stop ethambutol and refer to the Medical Officer,Stop rifampicin,Stop rifampicin and refer to the Medical Officer,Give drugs with small meals or just before bedtime,Advise patient to swallow pills slowly with small sips of water,Advise patient to swallow pills slowly with small sips of water ; If symptoms persist or worsen refer to hospital,Pyridoxine 50 -100mg daily,Reassurance, Counsel patients before starting treatment,encourage increase fluid intake,Reassure and counsel patients before starting treatment and encourage increase fluid intake,Give drugs before bedtime,Change intermittent to daily rifampicin administration"/></td>
                    <td><obs conceptId="167002"/></td>
                </obsGroup>
            </tr>
        </table>
    </fieldset>
    <!--TB Regimen & Duration at Dot Facility-->
    <fieldset>
        <legend class="legend_style">Tb Regimen to be continued at DoT Facility</legend>
        <table class="baseline-aligned">
            <tr>
                <td>
                    <label>Drugs</label>

                </td>
                <td>
                    <label>Strength</label>
                </td>
                <td>
                    <label>Frequency</label>
                </td>
                <td>
                    <label>Duration </label>
                </td>
                <td>
                    <label>Qty Prescribed</label>
                </td>

            </tr>
            <tr>
                <obsgroup groupingConceptId="165728">
                    <td>
                        <obs class='gridmenu' id="tb_drug" conceptId="165304" answerConceptIds="1675,768,656,1108" answerLabels="RHZE,RHZ,RHE,EH" />
                    </td>
                    <td>
                        <obs class='gridmenu' conceptId="165725" answerConceptIds="166061,165622,166062,162401,5622" answerLabels="150mg/75mg,300mg/150mg,150mg/75mg/40mg,Kit,Others" />
                    </td>
                    <td>
                        <obs class='gridmenu' conceptId="165723" answerConceptIds="160862,160858,165721,166056,166057,160870,165722,166058,5622" answerLabels="OD,BD,2 BD,3 BD,4 BD,QDS,3ce/week,Nocte,Others" />
                    </td>
                    <td>

                        <obs conceptId="166838" answerConceptIds="166667,166668,166670,166671" answerLabels="2 months,4 months,10 months,12 months" />

                    </td>
                    <td>
                        <obs conceptId="160856" id="qtyPrescribed" />
                    </td>

                </obsgroup>
            </tr>
            <tr>
                <obsgroup groupingConceptId="165728">
                    <td>
                        <obs class='gridmenu' id="tb_drug" conceptId="165304" answerConceptIds="83352,656,767,82900,75948" answerLabels="Rifabutin,HIGH DOSE ISONIAZID,RIFAMPICIN,Pyrazinamide,Ethambutol" />
                    </td>
                    <td>
                        <obs class='gridmenu' conceptId="165725" answerConceptIds="166063,165075,165074,165076,166054,5622" answerLabels="1g,150mg,300mg,100mg,400mg,Others" />
                    </td>
                    <td>
                        <obs class='gridmenu' conceptId="165723" answerConceptIds="160862,160858,165721,166056,166057,160870,165722,166058,5622" answerLabels="OD,BD,2 BD,3 BD,4 BD,QDS,3ce/week,Nocte,Others" />
                    </td>

                    <td>
                        <obs conceptId="166838" answerConceptIds="166667,166668,166670,166671" answerLabels="2 months,4 months,10 months,12 months" />
                    </td>

                    <td>
                        <obs conceptId="160856" id="qtyPrescribed" />
                    </td>

                </obsgroup>
            </tr>
        </table>
    </fieldset>
    <!--Last part of the form-New facility contact details-->
    <fieldset>
        <legend class="legend_style">STBLCO and Focal Person Contact</legend>
        <table border="0" width="100%" Height="350%">
            <tr>
                <td width="60" height="50"> Name of STBLCO Patient is Discharged to:<br/>
                    <obs conceptId="166810"  />
                </td>
                <td width="60" height="50"> Phone No of STBLCO<br/>
                    <obs conceptId="166811"  />
                </td>
            </tr>
            <tr>
                <td width="60" height="50"> Name of State DR-TB Focal Person:<br/>
                    <obs conceptId="166812"  />
                </td>
                <td width="60" height="50"> Phone No of State DR-TB Focal Person<br/>
                    <obs conceptId="166813"  />
                </td>
            </tr>
            <tr>
                <td width="60" height="50"> Name of Treatment Centre Doctor:<br/>
                    <obs conceptId="166814"  />
                </td>
                <td width="60" height="50"> Phone No of Treatment Centre Doctor<br/>
                    <obs conceptId="166815"  />
                </td>
            </tr>
            <tr>
                <td width="60" height="50"> Name of Treatment Centre Matron:<br/>
                    <obs conceptId="166816"  />
                </td>
                <td width="60" height="50"> Phone No of Treatment Centre Matron<br/>
                    <obs conceptId="166817"  />
                </td>
            </tr>
        </table>

    </fieldset>



    <fieldset>
        <legend class="legend_style"><em>Encounter Date and Signature</em></legend>
        <table class="table" width="100%">
            <tr>

                <td class="alnright_s">Visit Date:</td>
                <td class="alnleft_s">
                    <encounterDate id="encounter_Date " showTime="false" allowFutureDates="false"/>
                </td>
                <td class="alnleft_s">Provider's Name:</td>
                <td class="alnleft_s"><encounterProvider default="currentUser"/></td>

                <td class="alnright_s">Facility:</td>
                <td class="alnleft_s">
                    <encounterLocation default="SessionAttribute:emrContext.sessionLocationId"/>
                </td>
            </tr>
        </table>
    </fieldset>



    <submit/>

</htmlform>